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Abstract
Objective: Several transient receptor potential (TRP) channels are expressed in pancreatic beta cells and have been
proposed to be involved in insulin secretion. However, the endogenous ligands for these channels are far from clear. Here,
we demonstrate the expression of the transient receptor potential ankyrin 1 (TRPA1) ion channel in the pancreatic beta cells
and its role in insulin release. TRPA1 is an attractive candidate for inducing insulin release because it is calcium permeable
and is activated by molecules that are produced during oxidative glycolysis.
Methods: Immunohistochemistry, RT-PCR, and Western blot techniques were used to determine the expression of TRPA1
channel. Ca
2+ fluorescence imaging and electrophysiology (voltage- and current-clamp) techniques were used to study the
channel properties. TRPA1-mediated insulin release was determined using ELISA.
Results: TRPA1 is abundantly expressed in a rat pancreatic beta cell line and freshly isolated rat pancreatic beta cells, but not
in pancreatic alpha cells. Activation of TRPA1 by allyl isothiocyanate (AITC), hydrogen peroxide (H2O2), 4-hydroxynonenal (4-
HNE), and cyclopentenone prostaglandins (PGJ2) and a novel agonist methylglyoxal (MG) induces membrane current,
depolarization, and Ca
2+ influx leading to generation of action potentials in a pancreatic beta cell line and primary cultured
pancreatic beta cells. Activation of TRPA1 by agonists stimulates insulin release in pancreatic beta cells that can be inhibited
by TRPA1 antagonists such as HC030031 or AP-18 and by RNA interference. TRPA1-mediated insulin release is also observed
in conditions of voltage-gated Na
+ and Ca
2+ channel blockade as well as ATP sensitive potassium (KATP) channel activation.
Conclusions: We propose that endogenous and exogenous ligands of TRPA1 cause Ca
2+ influx and induce basal insulin
release and that TRPA1-mediated depolarization acts synergistically with KATP channel blockade to facilitate insulin release.
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Introduction
The Transient Receptor Potential (TRP) channels TRPC
(canonical), TRPV (vanilloid), TRPM (melastatin), TRPP (poly-
cystin), TRPML (mucolipin), and TRPA (ankyrin) are involved in
diverse functions that include transduction of sensory information,
cell growth/death, and neurotransmitter/hormone release [1].
Nociceptive TRP channels expressing C-fibers have been shown to
innervate the pancreas and are involved in carrying pain sensation
and glucose homeostasis. Proinflammatory agents that activate/
sensitize TRP channels can cause neurogenic inflammation and
pain. Nociceptors express these TRP channels and mediate the
excruciating pain associated with pancreatitis [2–4]. However, it is
becoming evident that several of these TRP channels are
expressed in nonsensory tissues and are involved in functions
other than somatic sensation, which include their expression in
pancreatic beta cells and involvement in insulin release. TRPV1
has been shown to modulate insulin secretion in rat pancreatic
beta cells [5]. Both TRPV1 and TRPA1 are functionally expressed
in pancreatic INS-1 beta cells [6] and RINm5F cells [7]. TRPV2-
mediated insulin release by high glucose stimuli is significantly
reduced after TRPV2 knockdown [8]. Amyloid polypeptide-
induced an increase in intracellular Ca
2+ in pancreatic beta cells is
mediated by TRPV4 [9]. TRPM2 is highly expressed in
pancreatic beta cells and regulates insulin release [10,11].
Activation of TRPM3 channel by the neurosteroid pregnenolone
sulphate triggers Ca
2+ influx and promotes insulin release [12].
TRPM4 has been shown to control insulin secretion in pancreatic
beta cells [13,14], and recently, a role for TRPM5 was indicated
by the finding of altered Ca
2+ oscillations in beta cells from
TRPM5 knockout animals [15]. Although these TRP channels are
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release, the efficacy and the endogenous ligands for these channels
are far from clear.
TRPA1 is a Ca
2+ permeable nonselective cation channel, which
is expressed in trigeminal and dorsal root ganglion neurons [16].
TRPA1 has been shown to be activated by several reactive
electrophilic food ingredients and irritants like allyl isothiocyanate
(AITC), cinnamaldehyde, allicin and acrolein, but also by non-
reactive sensory compounds like methylsalicylate and icilin [17–
21]. It has been proposed that TRPA1 is involved in various
sensory processes, such as the detection of noxious cold,
mechanosensation, and inflammatory hyperalgesia [16,17,22–
26]. TRPA1 is an attractive candidate to be involved in insulin
release because it can be activated by molecules that are produced
during oxidative phosphorylation such as hydrogen peroxide
(H2O2) and 4-Hydroxynonenal (4-HNE) and cyclopentenone
prostaglandins (PGJ2) [27,28]. Methylglyoxal (MG) is formed
from triose phosphates during secondary glucose metabolism in
hyperglycemic condition. It is well known that MG covalently
modifies arginine, lysine and cysteine residues and forms advanced
glycation end products, leading to hyperglycemia-induced tissue
damage [29–31]. It has been reported that MG has been shown to
cause membrane depolarization and insulin release in rat
pancreatic beta cells [32,33]. Given the finding that TRPA1 can
be activated by covalent modifying agents [34,35], we propose that
MG can be a potential agonist for TRPA1.
Pancreatic beta cells in the islets of Langerhans release insulin in
response to increases in blood glucose levels. This involves the
production of adenosine triphosphate (ATP) that blocks ATP-
sensitive potassium (KATP) channels, which depolarizes beta cells
and promotes Ca
2+ influx [36]. During glucose metabolism,
reactive oxygen species (ROS) and MG are produced as
byproducts [27,37–39]. We hypothesize that activation of TRPA1
by these metabolites could play a role in insulin release from
pancreatic beta cells. Further, a number of studies have proposed
that there is a KATP channel-independent pathway of insulin
release in pancreatic beta cells. Since this pathway is also activated
by glucose metabolism, it is considered to be an amplifying
pathway. But the mechanisms underlying this amplification
process are not fully understood [40–42].
In this study, we have characterized the expression and function
of TRPA1 channels in pancreatic beta cells using a rat beta cell
line (RINm5F cells) and freshly isolated rat pancreatic islets. We
show utilizing a variety of techniques that activation of TRPA1 by
endogenous and exogenous ligands causes membrane depolariza-
tion, Ca
2+ influx and insulin release.
Methods
Isolation of rat pancreatic islets and beta cells
All procedures used in this study were approved by the animal
care and use committee at Southern Illinois University, School of
Medicine, and conformed according to National Institutes of
Health and institutional guidelines. Sprague Dawley rats (Harlan
laboratories, Indianapolis, IN, USA) were anesthetized using
intraperitoneal injection of ketamine (85 mg/kg) and xylazine
(10 mg/kg). The common bile duct was clamped and cannulated
with a blunt needle. The pancreas was distended with 5 ml of cold
Hanks’ balanced salt solution containing collagenase 1 mg/ml
(Roche chemicals, Indianapolis, IN, USA) and 7.5 mM CaCl2
with pH 7.8. The pancreas was removed and incubated for
15 min in a water bath at 38uC. After centrifugation, the pellet
was washed twice and filtered through a mesh filter. Following
centrifugation, the pellet was resuspended in 1.080 g/ml optiprep
and layered under a discontinuous optiprep gradient (1.075, 1.070,
and 1.060) (Sigma Aldrich, St Louis, MO, USA). After centrifu-
gation, the tissue at the 1.070/1.060 interface was collected and
cultured in Rosewell Park Memorial Institute (RPMI) 1640
medium (Invitrogen, Carlsbad, California, USA) supplemented
with 10% FBS and antibiotics. In some of the experiments
individual islets were used. For other studies, islets were digested
into individual cells by incubation with trypsin and plated on the
cover slips.
Cell culture and transfection
For cell culture studies, human embryonic kidney (HEK) 293T
cells (Clontech Laboratories, Inc, Palo Alto, CA, USA) were
cultured in DMEM with 10% fetal bovine serum (FBS) and
penicillin (50 units/ml)-streptomycin (25 mg/ml) (Gibco-Invitro-
gen, Carlsbad, California, USA). TRPA1 cDNA and GFP cDNA
were co-transfected into HEK 293T cells with Lipofectamine 2000
reagent following manufacture’s protocol (Invitrogen, Carlsbad,
California, USA). The fluorescent cells were used for recording
currents 24 hrs after transfection. The non-fluorescent cells were
used as a negative control. RINm5F cells (rat pancreatic beta cell
line) and INR1G9 cells (hamster glucagonoma alpha cell line) were
gift from Henry Cheng, Louisiana State University, Baton Rouge,
LA, and grown in medium supplemented with 10% FBS.
Immunohistochemistry and peptide absorption studies
Rats were anesthetized using intraperitoneal injection of
ketamine (85 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) and
perfused transcardially with 4% paraformaldehyde. The pancreas
was harvested and quickly frozen. The pancreas was cut into
30 mm sections using a microtome (Leica CM 1850, North Central
Instruments Inc, Plymouth, MN, USA). The sections were rinsed
in 0.1 M PBS, and permeabilized with 1% triton X-100 in PBS for
30 minutes. The sections were then blocked in 10% normal
donkey serum in PBS for 30 minutes. The sections were incubated
with rabbit anti-TRPA1 antibody (1:100, Osenses, Australia) and
mouse anti-insulin antibody (1:200, Millipore, Billerica, MA, USA)
overnight at 4uC. Rhodamine donkey anti-mouse IgG (1: 100,
Jackson Immunoresearch Laboratories Inc., West Grove, PA,
USA) and FITC donkey anti-rabbit/guinea pig IgG (1: 100,
Jackson Immunoresearch) were used. Images were captured by a
fluorescence microscope.
For peptide absorption studies, TRPA1 blocking peptide (1:50,
Osenses, Australia) that was used to generate the antibody was
incubated with TRPA1 antibody for 1 hr at room temperature
before the experiment. The sections were incubated with the
mixture of TRPA1 peptide and rabbit anti-TRPA1 antibody
(1:100, Osenses, Australia) and mouse anti-insulin antibody (1:200,
Millipore, Billerica, MA, USA) overnight at 4uC. Rhodamine
donkey anti-mouse IgG (1: 100, Jackson Immunoresearch
Laboratories Inc., West Grove, PA, USA) and FITC donkey
anti-rabbit/guinea pig IgG (1:100, Jackson Immunoresearch) were
used. Images were captured by a fluorescence microscope.
Total RNA extraction and RT-PCR
Total RNA was extracted by Trizol reagent (Invitrogen Co.,
Carlsbad, California, USA) from rat dorsal root ganglia (DRG),
rat islets, rat pancreas, RINm5F cells and INR1G9 cells and
cDNAs prepared by reversely transcriptioned to cDNAs using a
cDNA sythesis kit (Promega Corporation, Madison, WI, USA).
PCR was performed by using different cDNAs as templates in 35
cycles with 30 s denaturation at 95uC, 30 s annealing at 58uC, and
30 s extension at 68uC by using PCR green master mix (Promega
Corporation, Madison, WI, USA). The PCR primers for rats were
TRPA1-Mediated Insulin Release
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CAGTTCCACCTGCATAGCAA; b-actin, F: AGCCATG-
TACGTAGCCATCC, R: AGGAAGGAAGGCTGGAAGAG.
The PCR products were electrophoresed in 1.5% agarose gel
with ethidium bromide in TBE buffer. The gel was scanned by
Versa Doc imaging system (Bio-Rad, Hercules, CA, USA) and the
blot band density was quantified by Quantity One (Bio-Rad).
Western blotting
RINm5F cells were collected in a lysis buffer (0.1% SDS, 1%
Triton X-100, 1% deoxycholate, protease and phosphatase
inhibitor cocktail, 1:100, Sigma Aldrich, St Louis, MO, USA),
homogenized and centrifuged. The protein concentration was
measured by the bicinchoninic acid (BCA) assay. Proteins were
separated by 10% SDS-PAGE and transferred to a nitrocellulose
membrane (Bio-Rad, Hercules, CA). Membranes were probed
overnight with rabbit anti-TRPA1 (1:500, Osenses, Australia) and
b-actin (1:200, Sigma Aldrich, St Louis, MO, USA) antibodies
followed by incubation with horseradish peroxidase-conjugated
(HRP) goat anti-rabbit IgG (1:10,000, Santa Cruz biotechnology
Inc., Santa Cruz, CA, USA) for 1 hr. After incubation with
enhanced chemiluminescence reagents (Santa Cruz biotechnology
Inc.), membranes were analyzed using a Hitachi Genetic Systems
(Hitachi Software Engineering, Japan).
Ca
2+ fluorescence imaging
RINm5F cells and cultured primary pancreatic beta cells grown
on glass cover slips were incubated with 3 mM Fluo-4 AM
(Invitrogen) for 30 min at 37uC and washed with physiological
buffer containing the following (in mM): 140 NaCl, 10 HEPES, 2
CaCl2, 1.2 MgCl2, 5 KCl, 5.5 glucose, pH 7.35. Fluo-4 was
excited at 488 nm, and emitted fluorescence was filtered with a
535625 nm band pass filter. The ratio of the fluorescence change




RINm5F cells and cultured primary pancreatic beta cells grown
on poly-D-lysine-coated cover slips were used for recording
TRPA1 currents. For whole-cell patch-clamp recordings, the bath
solution contained (in mM): 140 Na gluconate, 5 KCl, 10 HEPES,
1 MgCl2, 1.5 EGTA/2 CaCl2, pH adjusted to 7.35 with NaOH
and the pipette solution contained (in mM): 140 K gluconate, 5
KCl, 10 HEPES, 2 MgCl2, 10 EGTA, 2 K2ATP, 0.5 GTP, pH
adjusted to 7.35 with KOH. Currents were recorded with a
holding potential at 260 mV using an Axopatch 200B integrating
patch-clamp amplifier (Axon Instruments Inc.). Membrane
potentials and action potentials were recorded in the current-
clamp mode. All experiments were conducted at room tempera-
ture. Data were digitized (VR-10B; InstruTech, Great Neck, NY)
and stored on a computer using a LabView interface (National
Instruments). For analysis, data were filtered at 2.5 kHz (23d B
frequency with an eight-pole low-pass Bessel filter; LPF-8; Warner
Instruments) and digitized at 5 kHz. Current amplitudes and
membrane potentials were measured using Channel 2 (software
kindly provided by Michael Smith, Australian National University,
and Canberra, Australia).
Insulin release assays
Insulin release studies were performed in both RINm5F cells
and isolated pancreatic islets. RINm5F cells were cultured in 12-
well plates for 24 hrs and used for measuring insulin release. After
equilibration with Kreb-Ringer (KR) solution containing (in mM):
NaCl 136, KCl 4.8, CaCl2 2.5, KH2PO4 1.2, MgCl2 1.2,
NaHCO3 5, HEPES 10 and 0.05% BSA, the cells were incubated
with AITC, MG, 4-HNE, PGJ2 and HC 030031 for 1 hr in 0.4 ml
KR solution and the solution was collected. The insulin content
was measured by using ultra sensitive rat insulin ELISA kits
(Crystal Chem Inc. Downers Grove, IL, USA) according to the
manufacturer’s protocol. For insulin release studies in isolated
islets, they were cultured overnight in RPMI 1640 medium. Five
islets in each group were hand-picked and incubated with or
without treated reagents in 0.5 ml KR solution at 37uC for
15 min. Then the supernatants were collected for ELISA assay
using ultra sensitive rat insulin ELISA kits (Crystal Chem Inc.
Downers Grove, IL, USA).
Short interference RNA (siRNA) knockdown of TRPA1
siRNA sequences were designed from the rat TRPA1 sequence
and synthesized by Ambion (Austin, TX, USA). The siRNAs
against rat TRPA1 were as follows: F: GGUCCAACAUAACCG-
CAUATT; R: UAUGCGGUUAUGUUGGACCAT and nega-
tive control siRNA provided by the manufacturer (proprietary and
the sequence was not disclosed) were used as mock transfected
(Ambion Inc., Austin, TX, USA). The siRNAs were transfected
using lipofectamine 2000 reagent (Invitrogen Co.) following the
manufacturer’s protocol. The cells were used 2–3 days after
transfection.
Data analysis
Data are represented as mean 6 S.E.M. (Standard Error of the
Mean). Student’s t-test and one way analysis of variance (ANOVA)
were used for statistical comparisons and the significance is
considered at P,0.05.
Results
Expression of TRPA1 in pancreatic beta cells
Using RT-PCR technique, the presence of TRPA1 channel was
detected in dorsal root ganglion (DRG), pancreas (Pan) and
pancreatic islets (Isl), and in rat pancreatic beta cell line RINm5F
(RIN), but not in a hamster pancreatic alpha cell line, INR1G9
(INR) (Fig. 1a). TRPA1 protein was detected in RIN cells using
Western blot technique (Fig. 1b). In addition, immunohistochem-
ical studies revealed that TRPA1 was abundantly and selectively
expressed in pancreatic islets and TRPA1-positive cells were co-
stained with insulin in rat pancreatic islets (Fig. 1c). The specificity
of antibody binding was confirmed by preabsorbing the antibody
by incubating with a TRPA1 blocking peptide (Fig. 1c).
Functional characterization of TRPA1 in pancreatic beta
cells by Ca
2+ fluorescent imaging
We characterized the TRPA1 channel function in pancreatic
beta cells using Ca
2+ fluorescence imaging. Exposure of RIN cells
to the exogenous TRPA1 agonist allylisothiocyanate (AITC,
200 mM) induced a significant increase in intracellular Ca
2+ levels
(similar in magnitude to those observed in DRG neurons (fold
change, beta cells, 1.3860.03, n=28; DRG neurons 1.4160.03,
n=26) (Fig. 2a, b). In an effort to identify novel endogenous
ligands, we used the dicarbonyl compound methylglyoxal (MG),
which is produced during glucose metabolism and in higher levels
in hyperglycemic conditions. MG (200 mM) induced a significant
increase in intracellular Ca
2+ levels (fold change 1.3560.03,
n=28) in RIN cells (Fig. 2a, b). In the presence of a TRPA1
antagonist, HC 030031 (100 mM), MG-induced elevation of
intracellular Ca
2+ levels was completely blocked (Fig. 2c). MG
(1–1000 mM) dose dependently increased Ca
2+ influx in RIN cells
TRPA1-Mediated Insulin Release
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such as PGJ2 (20 mM), 4-HNE (100 mM) and H2O2 (500 mM),
induced significant Ca
2+ influx in RIN cells (fold change, H2O2,
1.2160.02, n=23; 4-HNE, 1.3760.04, n=27; PGJ2, 1.3260.03,
n=20) (Fig. 2d, e). AITC (200 mM) and MG (200 mM) also
induced Ca
2+ influx in freshly isolated primary beta cells from rats
(fold change, AITC, 1.1760.01; MG, 1.1960.03, n=17) (Fig. 2f).
In the absence of extracellular Ca
2+, application of TRPA1-
agonists did not induce an increase in intracellular Ca
2+ levels,
thus ruling out the possibility of Ca
2+ release from an intracellular
source. In similar experimental conditions, application of AITC,
MG, 4-HNE, PGJ2 or H2O2 did not increase intracellular Ca
2+
levels in a pancreatic alpha cell line (data not shown).
Functional characterization of TRPA1 in pancreatic beta
cells by electrophysiological techniques
We used voltage-clamp technique and recorded TRPA1-
mediated currents from primary rat pancreatic beta cells and
RIN cells. In primary rat pancreatic beta cells, significant
membrane currents were induced by application of MG
(400 mM) (10.861.3 pA/pF, range 6.0–25.1 pA/pF, n=15) and
AITC (200 mM) (17.262.9 pA/pF, range 7.1–33 pA/pF, n=18)
(Fig. 3a). Relatively high concentrations (.100 mM) of MG were
required to elicit currents or cause Ca
2+ influx. The concentration
of MG in the plasma has been estimated to be between 1–2 mMi n
normal individuals and 2–5 mM in hyperglycemic conditions [43].
However, the cytoplasmic concentration of MG is not known. We
reasoned that being a reactive molecule generated intracellularly,
MG may not cross the plasma membrane readily. Therefore, we
exposed the intracellular surface of the membrane to MG by
including different concentrations of MG (0.03 to 10 mM) in the
pipette solution. The current recordings were started as soon as the
whole-cell configuration was achieved by applying negative
pressure. In this condition, MG-induced currents in the sub-
micromolar range. The EC50 value was found to be 0.59 mM
(Fig. 3b). Interestingly, currents induced by 1 and 10 mMM G
differed in the activation phase (10–90% rise time: 1 mM
134613.9 s, n=3; 10 mM, 8066.8 s, n=3), but almost had
similar amplitudes in a few experiments (1 mM, 8.1860.98 pA/
pF, n=4; 10 mM, 11.1860.97 pA/pF, n=3) (Fig. 3b, inset)
suggesting that even lower concentrations of MG could induce
maximal responses over time. Intracellular MG-induced current
was blocked completely by TRPA1 antagonist (AP-18, 50 mM)
applied extracellularly (Fig. 3c). Similarly, in RIN cells the TRPA1
agonists AITC, MG, 4-HNE, and PGJ2 induced currents, that
were blocked by HC030031 (100 mM) (Fig. S2). In order to
compare the characteristics of TRPA1-mediated currents in the
pancreatic beta cells, we recorded currents from HEK293T cells
heterologously expressing TRPA1. MG (400 mM) induced cur-
rents (15.060.6 pA/pF, n=13) of similar magnitude to that
induced by AITC (200 mM) (19.160.7 pA/pF, n=10) (Fig. 3d).
As demonstrated in pancreatic beta cells, TRPA1 agonist evoked
currents in HEK cells were completely blocked by a selective
TRPA1 antagonist (AP-18, 100 mM) (Fig. 3e).
Next, using the current-clamp technique, we showed that
application of AITC (20 mM) and MG (500 mM) induced
membrane depolarizations (AITC, 26.161.9 mV, n=9; MG,
24.163.1 mV, n=11) and increased the frequency of action
potentials (AITC, 0.1760.11 to 0.8760.14 Hz, n=6; MG,
0.0460.04 to 1.1260.28 Hz, n=4) in primary pancreatic beta
cells, which could be blocked by HC030031 (100 mM) (AITC,
3.3861.97 mV, n=5; MG, 1.2662.61 mV, n=6). Figure 3f
shows that extracellular application of MG (500 mM) induced a
depolarization that could be blocked by HC030031 (100 mM). As
shown in voltage-clamp experiments, when a lower concentration
of MG (2 mM) was included in the pipette solution, it induced
significant membrane depolarization (21.562.5 mV, n=7) and
increased the frequency of action potentials (0.0860.04 to
1.1460.24 Hz, n=5). This effect could also be blocked by
HC030031 (100 mM) applied extracellularly (1.2662.61 mV,
n=6) (Fig. 3g).
Figure 1. Expression of TRPA1 in pancreatic beta cells. a. RT-PCR shows the expression of TRPA1 mRNA in DRG neurons, whole pancreas (Pan),
isolated islets (Isl), a pancreatic beta cell line (RIN), but not in a pancreatic alpha cell line (INR). b. Western blots show the expression of TRPA1 protein
in RIN cells and HEK cells heterologously expressing TRPA1. c. Immunostaining of insulin (red), TRPA1 (green), and the co-expression (yellow) in the
pancreatic islet (top panel). When the slices were incubated with the TRPA1 antibody after preabsorbing with a peptide used for making the
antibody, the TRPA1 staining was considerably reduced (lower panel). The nuclei were stained with DAPI (scale bar=100 mM).
doi:10.1371/journal.pone.0038005.g001
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In order to determine the physiological relevance of TRPA1
expressed in pancreatic beta cells, we investigated the ability of
TRPA1 agonists to cause insulin release in RIN cells and isolated
intact islets from rat pancreas. In RIN cells, application of AITC
(0.1–1000 mM) and MG (0.1–1000 mM) caused a dose-dependent
increase in insulin release (Fig. 4a, b). Since we do not know the
intracellular concentrations of MG achieved, the EC50 value
obtained by extracellular application is only used to compare the
relative potency between agonists. In intact islets, AITC (100 mM)
Figure 2. TRPA1-mediated Ca
2+ influx in pancreatic beta cells. a, b. Application of AITC and MG induce an increase in intracellular Ca
2+ in RIN
cells (size of the bar is 100 mM). c. MG-induced Ca
2+ influx is inhibited by TRPA1 antagonist HC030031. d. Ca
2+ influx induced by endogenous ligands
PGJ2, 4-HNE, and AITC in RIN cells. e. Ca
2+ influx induced by H2O2 and AITC in RIN cells. f. AITC-and MG-induced an increase in intracellular Ca
2+ in rat
cultured primary pancreatic beta cells.
doi:10.1371/journal.pone.0038005.g002
Figure 3. TRPA1-mediated membrane currents in primary pancreatic beta cells. a. Membrane currents induced by extracellular application
of MG and AITC in primary pancreatic beta cells. b. A concentration-response curve of membrane currents induced by MG included in the pipette
solution in primary beta cells (EC50=0.59 mM). Lower concentrations (,1 mM) of MG are sufficient to induce maximal currents when applied
intracellulary (inset), but the time to peak with lower concentrations is longer and the desensitization is profound at higher concentrations. c.
Currents evoked by intracellular application of MG are reversibly blocked by extracellular application of AP-18. d. Currents elicited by MG and AITC in
HEK 293T cells heterologously expressing TRPA1. e. MG-induced currents can be blocked by AP-18. f. Under current clamp conditions, extracellular
application of MG depolarizes the membrane and generates action potentials that could be blocked by HC030031. g. Intracellular application of MG
causes a robust depolarization and generates action potentials that could be blocked by HC030031.
doi:10.1371/journal.pone.0038005.g003
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MG (100 mM) (basal 1.6960.32, MG, 3.0060.69 ng/ml, n=10,
p,0.01) induced significant insulin release that could be blocked
by incubation with AP-18 (100 mM) (AITC+AP-18,
1.7960.20 ng/ml, n=6, p,0.001; MG+AP-18, 1.5860.42 ng/
ml, n=6, p,0.01) (Fig. 4c.d). We also determined insulin release
caused by other TRPA1 agonists. In RIN cells 4-HNE (100 mM)
3.9660.28 ng/ml, n=6, p,0.001 and PGJ2 (100 mM)
3.5960.51 ng/ml, n=6, p,0.001) induced significant increases
in insulin release that were inhibited by HC030031 (100 mM) (4-
HNE+HC, 0.2860.05 ng/ml, n=3, p,0.001; PGJ2+HC,
0.6660.17 ng/ml, n=3, p,0.001) (Fig. 4 e, f).
In order to examine the role of TRPA1 in glucose-induced
insulin release, we determined insulin release in response to
incubation of cells with glucose (6 and 25 mM) and tested the
effect of a TRPA1 antagonist. A dose-dependent increase in
insulin release was observed with increasing concentrations of
glucose (6 mM, increased from 1.2860.12 to 2.5060.16 ng/ml,
n=8, p,0.001; 25 mM, 4.2760.48 ng/ml, n=9, p,0.001)
(Fig. 5a). Glucose-induced insulin release could be partially
inhibited by HC030031 (100 mM) (6 mM, decreased from
2.5260.16 to 1.0560.12 ng/ml, n=4, p,0.001; 25 mM, de-
creased from 4.2860.48 to 1.5260.44 ng/ml, n=7 p,0.001)
(Fig. 5b), suggesting that TRPA1 plays a role in glucose-induced
insulin release. Further, AITC-induced insulin release at different
concentrations of glucose (6 mM, increased from 2.6260.14 to
6.2561.46 ng/ml, n=4, p,0.01; 25 mM, increased from
4.3761.17 to 10.9361.18 ng/ml, n=4, p,0.05) could be
significantly inhibited by HC030031 (100 mM) (6 mM,
1.6460.48 ng/ml, n=4, p,0.001; 25 mM, 2.4760.88 ng/ml,
n=7p,0.001) (Fig. 5c).
TRPA1-mediated insulin release is independent of
voltage-gated Na
+ and Ca
2+ channels or KATP channels
In order to address whether Ca
2+ influx caused by TRPA1
activation is sufficient to induce insulin release or whether




2+ channels are required, we
used tetrodotoxin (TTX) to block voltage-dependent Na
+ channels
and nimodipine to block voltage-gated Ca
2+ channels in RIN cells.
AITC significantly increased insulin levels (from 1.2960.04 to
1.9760.12 ng/ml). In the presence of TTX (1 mM), insulin release
was significantly inhibited (1.1560.03 ng/ml, n=6, p,0.01),
however, when stimulated by AITC (100 mM) in the presence of
TTX, insulin release was significantly increased (1.5260.09 ng/
ml, n=6, p,0.05) suggesting a direct role of TRPA1-mediated
Ca
2+ flux in insulin release (Fig. 6a). In the presence of voltage-
gated Ca
2+ channel blocker nimodipine (5 mM), the basal insulin
release was significantly reduced (from 1.3160.05 to
1.0960.04 ng/ml, n=6, p,0.05), but following administration
of AITC in the presence of nimodipine, a significant increase in
insulin release was observed (1.5860.07 ng/ml, n=6, p,0.01)
suggesting that activation of TRPA1 can induce insulin release
independent of voltage-gated Ca
2+ channels. Then, we used
diazoxide (200 mM) to activate KATP channels and keep the
membrane potential hyperpolarized. In this condition, a signifi-
cant decrease in basal insulin release occurred (from 1.3260.06 to
1.2160.22 ng/ml, n=6, p,0.05), but when challenged with
TRPA1 agonists in the presence of diazoxide, a significant increase
in insulin release was observed (1.6460.08 ng/ml, n=6, p,0.01),
suggesting KATP channel-mediated depolarization is not required
for TRPA1-mediated insulin release (Fig. 6c).
Figure 4. TRPA1-mediated insulin release in pancreatic beta cell line and primary isolated pancreatic islets. a,b. Dose-dependent
increase in insulin release induced by AITC (0.1–1000 mM, n=7) and MG (0.1–1000 mM, n=5) in RIN cells (* p,0.05). c,d. AITC and MG induce a
significant increase (AITC, n=11,* p,0.001; MG, n=10 * p=0.004) in insulin release from primary isolated pancreatic beta cell islets that could be
blocked by the specific TRPA1 antagonist AP-18 (AITC+AP-18, n=6, ** p,0.001; MG+AP-18, n=6, ** p=0.008). e. 4-HNE (100 mM)-induced insulin
release is inhibited by HC030031 (100 mM) (4-HNE, n=6, * p,0.001; 4-HNE+HC030031, n=3, ** p,0.001). f. PGJ2 (20 mM)-induced insulin release is
inhibited by HC030031 (100 mM) (PGJ2,n=6 ,*p ,0.001; PGJ2+HC030031, n=3, ** p,0.001).
doi:10.1371/journal.pone.0038005.g004
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In order to further confirm the specificity of involvement of
TRPA1 in inducing Ca
2+ influx and insulin release, the RIN cells
were transfected with short interference RNA (siRNA) designed to
knockdown TRPA1. Following siRNA transfection of pancreatic
beta cells, TRPA1 mRNA was not detected when compared to
mock transfected cells, confirming the efficiency of TRPA1
knockdown (Fig. 7a). In the presence of glucose (3 mM) AITC
(200 mM)-induced insulin release was significantly diminished
(from 3.3760.31 to 2.6060.15 ng/ml, n=6, p,0.05) in siRNA
transfected cells (Fig. 7b), but not in mock transfected cells. Ca
2+
influx evoked by TRPA1 agonists, but not by KCl was completely
abolished by TRPA1 knockdown in these cells (Fig. 7c). These
experiments further confirm TRPA1-mediated insulin release
from pancreatic beta cells.
Discussion
In this study, we have demonstrated the expression of TRPA1
in a pancreatic beta cell line (RIN) and freshly isolated rat
pancreatic islets using RT-PCR, Western blot and immunohisto-
chemical techniques. We have further studied the channel function
using Ca
2+ imaging and patch-clamp techniques to show that
activation of TRPA1 induces Ca
2+ influx and membrane
depolarization. Finally, we have demonstrated that activation of
TRPA1 by exogenous and endogenous agonists causes insulin
release.
A number of TRP channels have been shown to be expressed in
the pancreas and to be involved in insulin release and with our
findings TRPA1 is added to this list. But the relative importance of
these TRP channels expressed in the pancreatic beta cells is yet to
be clarified. Transcripts of the non-selective cation channels
TRPC1 and TRPC4, which mediate Ca
2+ influx following
stimulation of G-protein coupled receptors have been identified
[44–49]. TRPV1 has been shown to modulate insulin secretion
and TRPV2-mediated insulin release is significantly decreased
after TRPV2 knockdown [5,8]. TRPV4 is expressed in pancreatic
beta cells and increases intracellular Ca
2+ when activated by
amyloid polypeptide [9]. TRPM2, TRPM3, TRPM4, and
TRPM5 channels are associated with Ca
2+ influx in pancreatic
beta cells and involved in insulin release, in particular TRPM3 is
directly activated by the neurosteroid pregnenolone sulphate [10–
15]. It has been shown that TRPA1 is functionally expressed in
pancreatic beta cells and proposed to be involved in insulin release
[6,7].
Figure 5. Insulin release induced by different concentrations of glucose. a. Insulin release induced by different concentrations of glucose
(6 mM, n=8, * p,0.001; 25 mM, n=9, *p,0.001) b. Insulin release induced by different concentrations of glucose is inhibited by HC030031 (100 mM)
(6 mM, n=4, * p,0.001; 25 mM, n=7, * p,0.001, as compared to control). c. Insulin release induced by AITC (200 mM) in different concentrations of
glucose is inhibited by HC030031 (100 mM) (6 mM, AITC, n=4, * p,0.01, AITC+HC030031, n=4, ** p,0.001; 25 mM, AITC, n=4, * p=0.023,
AITC+HC030031, n=4, ** p,0.01).
doi:10.1371/journal.pone.0038005.g005
Figure 6. TRPA1-mediated insulin release is independent of voltage-gated Na
+,C a
2+ and KATP channels. a. AITC caused a significant
increase in insulin release (n=6, ** p,0.01). The basal insulin release is inhibited by incubation of RIN cells with TTX (1 mM) (TTX, n=6, * p,0.05.
When challenged with AITC (200 mM), there is a significant increase in insulin release AITC+TTX, n=6, * p,0.05 as compared to TTX. b. In the
presence of Ca
2+ channel blocker nimodipine (5 mM) basal insulin release is decreased significantly (n=6, * p,0.05), but there is a significant increase
when challenged with AITC+nimodipine (n=6,** p,0.01). c. In the presence of KATP channel opener, diazoxide (200 mM), basal insulin release is
significantly decreased (n=6, * p,0.05), when challenged with AITC, there is a significant increase in insulin release (n=3, ** p,0.01).
doi:10.1371/journal.pone.0038005.g006
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attractive candidate to be involved in insulin release because it is
activated by reactive molecules that are produced during oxidative
glycolysis. We have shown that in a pancreatic beta cell line and in
freshly isolated rat pancreatic beta cells, application of MG, 4-
HNE, PGJ2, and H2O2 is able to increase intracellular Ca
2+ levels
and cause membrane depolarization. We are able to demonstrate
that these agonists also cause insulin release. As we are applying
endogenous intracellularly produced molecules exogenoulsy, the
effective concentrations that are required to activate the channels
are not readily determined. In fact, while using MG as an agonist
in electrophysiological experiments, we found that exposure of
MG to the cytoplasmic surface of the membrane activated TRPA1
with much lower concentrations (EC50=590 nM) than the
concentrations required to induce a response when applied
extracellularly. Although, we have shown that H2O2 activates
TRPA1, it is also implicated in other functions. TRPM2 channels
have been shown to be activated by H2O2 and excessive Ca
2+
influx may induce beta cell death [45,50,51]. KATP channels
activity is also increased by H2O2 [50–52], which leads to
membrane hyperpolarization and inhibition of insulin secretion.
H2O2 can also cause ATP depletion, which can trigger Ca
2+
release from intracellular stores [53–55].
It is not clear in what circumstances TRPA1-mediated insulin
release comes into play. We are able to show that insulin release
induced by exogenous and endogenous ligands can be blocked by
TRPA1 antagonists. We have conducted experiments with
different concentrations of glucose to determine the role of
TRPA1 under normal physiological functions. Following incuba-
tion with TRPA1 antagonists, a significant decrease in glucose-
induced insulin release was observed suggesting that it has a role in
normal physiological conditions. In order to eliminate the
possibility of TRPA1-mediated generation of action potentials
and the involvement of voltage-gated channels in insulin release,
we incubated the cells with voltage-gated Na
+ channels blocker
(TTX) and voltage-gated Ca
2+ channel blocker (nimodipine).
Incubation with these blockers alone caused a decrease in insulin
release suggesting their role in the basal insulin release; however,
when challenged with TRPA1 agonists, a significant increase in
insulin release was observed. These results suggest that TRPA1-
mediated insulin release is independent of Ca
2+ flux through
voltage-gated Ca
2+ channels. In order to eliminate the role of
KATP channel-mediated depolarization, we incubated the cells
with the KATP channel activator, diazoxide. In the presence of
diazoxide there was a basal decrease in insulin release, however,
when challenged with TRPA1 agonists, a significant increase in
insulin release was observed. This is consistent with KATP channel-
mediated hyperpolarization increasing the driving force for Ca
2+
entry through TRPA1.
In general, insulin secretion is stimulated by glucose, hormones
and neurotransmitters. Glucose enters beta cells mainly via the
Glut-2 transporter and cytosolic glucose concentration is rapidly
adapted to the changes in blood glucose concentration. [52]. The
most predominant mechanism of insulin secretion in response to
increased blood glucose levels is by the triggering pathway brought
about by alteration in ATP/ADP ratio that results in the block of
KATP channel, membrane depolarization, Ca
2+ influx through
voltage-gated Ca
2+ channels, and exocytosis of insulin containing
vesicles [52]. An amplifying pathway due to sensitization of the
exocytotic machinery that is independent of KATP channel activity
has been identified [40–43,56,57]. Insulin release has been studied
under conditions, where KATP channels have been kept open by
diazoxide or closed by sulfonylurea. A significant increase in
insulin release has been observed with minimal or no change in
intracellular Ca
2+ levels [40–42]. The amplifying mechanism
strongly depends on metabolism of glucose, however, the signal/s
responsible for this phenomenon is/are not yet identified. Incretins
such as glucagon-like peptide 1 (GLP-1) induces depolarization,
which is independent of KATP channel inhibitions, it has been
suggested that GLP-1 may activate a TRP channels [58–60].
However, it is puzzling to learn that during the amplification
process, there was no increase in plasmalemma Ca
2+ concentra-
tion [42].
Based on the results presented in this study, we propose a
mechanism of insulin release in pancreatic beta cells involving the
TRPA1 ion channel. Under normal conditions the TRPA1-
mediated pathway may act as a low tone system to cause insulin
release to support the trophic functions. However, in hyperglyce-
mic conditions, production of ROS and MG can directly evoke
insulin release through this pathway, providing a novel signaling
mechanism leading to insulin release in addition to or in concert
with block of KATP channels.
Figure 7. TRPA1-medated insulin release and Ca
2+ influx
following knockdown of TRPA1 by siRNA a. RT-PCR after
knockdown of TRPA1 by siRNA in control and mock-transfected cells.
b. AITC (200 mM)-induced insulin release is significantly reduced after
siRNA knockdown of TRPA1 in RIN cells (n=6, * p,0.05). c. AITC
(200 mM) and MG (1 mM) induce increase in intracellular Ca
2+ levels in
mock-transfected RIN cells (upper panel), but not in siRNA treated cells
(lower panel). Note that siRNA treated cells responded to KCl (50 mM)
similar to that of mock-transfected cells.
doi:10.1371/journal.pone.0038005.g007
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Figure S1 MG-induced dose dependent increase in Ca
2+
influx. MG (1–1000 mM) evokes concentration-dependent
increases in [Ca
2+]i, with an EC50 value of 28.6 mM.
(TIF)
Figure S2 TRPA1-mediated membrane currents in RIN
cells. a. MG- and AITC-induced currents. b. MG-induced
current is blocked by HC030031. Currents induced by c. 4-HNE
and d. PGJ2 are blocked by HC030031 (100 mM).
(TIF)
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